Elizabeth A. Galloway, EVP and CHRO, has demonstrated a clear net buying bias in her transactions involving Brink’s Company (BCO), with $2.27 million in total purchases compared to $1.27 million in sales across 37 reported trades. The bulk of her activity appears concentrated in early 2026, with a significant acquisition on February 18, 2026, when she acquired shares worth $2.17 million alongside an $860,187 disposition—likely reflecting an option exercise and concurrent sale. Prior to this, her transactions were smaller and more frequent, consisting primarily of periodic acquisitions throughout 2025, often in symmetrical pairs (e.g., two purchases of $5,480.58 each on November 28, 2025).
Recent filings show a shift toward dispositions, with Galloway executing sales of $37,950 and $42,908 on March 1 and March 3, 2026, respectively, alongside minor acquisitions. The pattern suggests a long-term accumulation phase followed by partial profit-taking, though her overall position remains weighted toward ownership. All activity is confined to BCO, indicating a singular focus on her employer’s stock. The absence of trades in other companies underscores a concentrated, company-specific strategy rather than diversified insider activity. The transactions, particularly the early 2026 block trade, likely relate to equity compensation events given their size and timing.
AI-assisted summary